S. Hahn

T. Zhu, S. Hahn, A. Yodh, 2000, Proceedings of the 22nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (Cat. No.00CH37143).

Photodynamic therapy with motexafin lutetium for rectal cancer: a preclinical model in the dog.

T. Zhu, S. Hahn, A. Yodh, 2006, The Journal of surgical research.

Patterns of recurrence in patients treated with photodynamic therapy for intraperitoneal carcinomatosis and sarcomatosis.

S. Hahn, D. Fraker, J. Metz, 2004, International journal of oncology.

Clinical trials of image‐guided interventions including radiotherapy studies

S. Hahn, G. Dorfman, 2016 .

Photoimmunotherapy and ovarian cancer: an improbable fiction or a palpable hit?

S. Hahn, E. Glatstein, Z. Tochner, 1999, Journal of the National Cancer Institute.

Free radical modes of cytotoxicity of adriamycin and streptonigrin.

S. Hahn, W. Degraff, M. Krishna, 1994, Biochemical pharmacology.

A low molecular weight antioxidant decreases weight and lowers tumor incidence.

James B. Mitchell, S. Hahn, A. Deluca, 2003, Free radical biology & medicine.

Nitroxide stable radicals protect beating cardiomyocytes against oxidative damage.

S. Hahn, J. Mitchell, A. Samuni, 1991, The Journal of clinical investigation.

Rates of unconventional medical therapy use in patients with prostate cancer: standard history versus directed questions.

S. Hahn, J. Metz, H. Jones, 2002, Urology.

Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy.

Jarod C Finlay, Timothy C Zhu, T. Zhu, 2005, Journal of photochemistry and photobiology. B, Biology.

In vivo reflectance measurement of optical properties, blood oxygenation and motexafin lutetium uptake in canine large bowels, kidneys and prostates.

Rex Cheung, T. Zhu, S. Hahn, 2002, Physics in medicine and biology.

Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.

S. Hahn, J. Cook, C. Lipschultz, 1993, Cancer research.

The catecholic metal sequestering agent 1,2-dihydroxybenzene-3,5-disulfonate confers protection against oxidative cell damage.

S. Hahn, W. Degraff, T. McMurry, 1992, Archives of biochemistry and biophysics.

Comparative treatment planning between proton and X-ray therapy in pancreatic cancer.

S. Hahn, J. Metz, H. Jones, 2001, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Redoubling Efforts to Help Americans Quit Smoking - Federal Initiatives to Tackle the Country's Longest-Running Epidemic.

S. Hahn, R. Redfield, N. Sharpless, 2020, The New England journal of medicine.

Taxol in Combination with Doxorubicin or Etoposide

James B. Mitchell, S. Hahn, D. Venzon, 1993 .

Supplement to Citizen Petition Docket No. FDA-2013-P-0435 Prohibit Menthol as a Characterizing Flavoring of Cigarettes and Cigarette Smoke

S. Hahn, 2021 .

Spin trap salvage from endotoxemia: the role of cytokine down-regulation.

S. Hahn, M. Merino, H. Pass, 1992, Surgery.

Optical property measurements using broadband reflectance spectroscopy in human tisues before and after photodynamic therapy

T. Zhu, S. Hahn, J. Metz, 2002 .

A multidrug-resistant breast cancer cell line induced by weekly exposure to doxorubicin.

S. Hahn, J. Cook, J. Mitchell, 1999, International journal of oncology.

Mn(III)-desferrioxamine superoxide dismutase-mimic: alternative modes of action.

S. Hahn, J. Mitchell, A. Samuni, 1991, Archives of biochemistry and biophysics.

Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol.

S. Hahn, W. Degraff, M. Krishna, 1991, Archives of biochemistry and biophysics.

In vivo light dosimetry for motexafin lutetium‐mediated PDT of recurrent breast cancer

Andreea Dimofte, T. Zhu, S. Hahn, 2002, Lasers in surgery and medicine.

Topical application of nitroxide protects radiation-induced alopecia in guinea pigs.

S. Hahn, J. Mitchell, T. Goffman, 1992, International journal of radiation oncology, biology, physics.

Proton therapy for head and neck cancer

S. Hahn, J. Lukens, A. Lin, 2015, Current opinion in oncology.

TRANSLATING PROTON DOSIMETRY INTO THE CLINIC : ATTEMPTS TO QUANTIFY

S. Hahn, J. Lukens, A. Lin, 2015 .

Evaluation of tempol radioprotection in a murine tumor model.

S. Hahn, D. Venzon, A. Deluca, 1997, Free radical biology & medicine.

Molecular Biology and Genetics of Lung Cancer

S. Hahn, S. Hahn, W. Mckenna, 2005 .

In vivo electron paramagnetic resonance imaging of tumor heterogeneity and oxygenation in a murine model.

James B. Mitchell, S. Hahn, J. Zweier, 1998, Cancer research.

Toxicity of photodynamic therapy after combined external beam radiotherapy and intraluminal brachytherapy for carcinoma of the upper aerodigestive tract

N. Sanfilippo, G. Ginsberg, S. Hahn, 2001, Lasers in surgery and medicine.

Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years.

S. Hahn, C. Simone, K. Cengel, 2017, The Annals of thoracic surgery.

Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma.

Keith Cengel, Joseph S Friedberg, Eli Glatstein, 2012, The Annals of thoracic surgery.

Photodynamic therapy for mesothelioma

S. Hahn, Ryan P. Smith, J. Friedberg, 2001, Current treatment options in oncology.

Photodynamic therapy and the evolution of a lung-sparing surgical treatment for mesothelioma.

S. Hahn, K. Cengel, R. Mick, 2011, The Annals of thoracic surgery.

Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread.

Timothy Zhu, Theresa M Busch, Andreea Dimofte, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors.

Timothy C. Zhu, Eli Glatstein, Todd W. Bauer, 2001 .

Short-term and long-term health risks of nuclear-power-plant accidents.

Eli Glatstein, Zelig Tochner, R. Forrest, 2011, The New England journal of medicine.

A Phase II Trial of Intraperitoneal Photodynamic Therapy for Patients with Peritoneal Carcinomatosis and Sarcomatosis

Timothy Zhu, Theresa M Busch, Andreea Dimofte, 2006, Clinical Cancer Research.

Identification of nitroxide radioprotectors.

S. Hahn, D. Venzon, W. Degraff, 1992, Radiation research.

Electron Paramagnetic Resonance Imaging of Tumor Heterogeneity and OxygÃ © nationin a Murine Model 1

James B. Mitchell, S. Hahn, J. Zweier, 2006 .

New directions for free radical cancer research and medical applications.

S. Hahn, J. Mitchell, C. Krishna, 1994, Advances in experimental medicine and biology.

Is there a role for salvage radiotherapy in locally advanced breast cancer refractory to neoadjuvant chemotherapy?

S. Hahn, L. Faroni, Ivone do Carmo, 2017, Breast.

Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling

Jarod C Finlay, Timothy C Zhu, Ken Kang-Hsin Wang, 2010, Journal of biophotonics.

Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription.

P. Lambin, S. Hahn, A. Hoffmann, 2016, Journal of the National Cancer Institute.

Motexafin Lutetium-Photodynamic Therapy of Prostate Cancer: Short- and Long-Term Effects on Prostate-Specific Antigen

Keith A. Cengel, Timothy C. Zhu, Jarod C. Finlay, 2008, Clinical Cancer Research.

Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer.

Timothy C Zhu, Theresa M Busch, Andreea Dimofte, 2006, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

Photodynamic therapy for the treatment of non-small cell lung cancer.

Charles B Simone, Keith A Cengel, Joseph S Friedberg, 2012, Journal of thoracic disease.

Vascularity and uptake of photosensitizer in small human tumor nodules: implications for intraperitoneal photodynamic therapy.

S. Hendren, S. Hahn, D. Fraker, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Intraperitoneal photodynamic therapy.

S. Hahn, K. Cengel, E. Glatstein, 2007, Cancer treatment and research.

Beating Cardiomyocytes against Oxidative Damage

James B. Mitchell, S. Hahn, A. Samuni, 1991 .

Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate

Timothy C Zhu, Jun Li, Martin D Altschuler, 2008, Physics in medicine and biology.

Preclinical Evaluation of Cetuximab and Benzoporphyrin Derivative‐Mediated Intraperitoneal Photodynamic Therapy in a Canine Model

Gwendolyn M. Cramer, S. Hahn, D. Fraker, 2020, Photochemistry and photobiology.

Hypoxia in human intraperitoneal and extremity sarcomas.

S. Hahn, D. Fraker, C. Koch, 2001, International journal of radiation oncology, biology, physics.

Proton therapy for head and neck cancer: current applications and future directions

S. Hahn, S. Swisher-McClure, A. Lin, 2012 .

Optical Properties of Human Prostate at 732 nm Measured In Vivo During Motexafin Lutetium–mediated Photodynamic Therapy¶

Timothy C. Zhu, Jarod C. Finlay, Andreea Dimofte, 2005 .

Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide ].

S. Hahn, C. Koch, S. Evans, 2000, Cancer research.

Correlation of in vivo photosensitizer fluorescence and photodynamic-therapy-induced depth of necrosis in a murine tumor model.

Arjun G Yodh, Theresa M Busch, Michael Solonenko, 2003, Journal of biomedical optics.

Future developments in radiation oncology for the management of carcinoma of the lung

S. Hahn, E. Glatstein, F. Sullivan, 1993 .

Interstitial Fluorescence Spectroscopy in the Human Prostate During Motexafin Lutetium–Mediated Photodynamic Therapy

Jarod C Finlay, Timothy C Zhu, Theresa M Busch, 2006, Photochemistry and photobiology.

Phase I trial of motexafin-lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer

Timothy C. Zhu, Debbie Smith, Jarod C. Finlay, 2004, SPIE BiOS.

In vivo Optical Properties of Normal Canine Prostate at 732 nm Using Motexafin Lutetium–mediated Photodynamic Therapy¶

Timothy C Zhu, Andreea Dimofte, Eli Glatstein, 2003, Photochemistry and photobiology.

Elevated Serum Cytokine Levels in Mesothelioma Patients Who Have Undergone Pleurectomy or Extrapleural Pneumonectomy and Adjuvant Intraoperative Photodynamic Therapy ¶

S. Hahn, S. Yom, E. Glatstein, 2003 .

Pathological Response to Preoperative Chemoradiation Worsens with Anemia in Non‐‐‐Small Cell Lung Cancer Patients

T. J. Robnett, S. Hahn, J. Shrager, 2002, Cancer journal.

Proton pencil beam scanning for mediastinal lymphoma: the impact of interplay between target motion and beam scanning

S Both, S. Hahn, S. Hahn, 2015, Physics in medicine and biology.

In vivo measurement of fluorescence emission in the human prostate during photodynamic therapy

Jarod C Finlay, Timothy C Zhu, Stephen M Hahn, 2005, SPIE BiOS.

Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.

S. Hahn, D. Fraker, A. Kachur, 1999, Cancer research.

Proton pencil beam scanning for mediastinal lymphoma: treatment planning and robustness assessment

S. Hahn, J. Plastaras, S. Both, 2016, Acta oncologica.

Protection against Adriamycin cytotoxicity and inhibition of DNA topoisomerase II activity by 3,4-dihydroxybenzoic acid.

James B. Mitchell, S. Hahn, L. S. Myers, 2003, International Journal of Oncology.

Phase II Trial of Debulking Surgery and Photodynamic Therapy for Disseminated Intraperitoneal Tumors

Timothy Zhu, Eli Glatstein, Todd W. Bauer, 2001, Annals of Surgical Oncology.

Proton therapy and sarcomas

S. Hahn, A. Bishop, 2021 .

Should randomized clinical trials be required for proton radiotherapy? An alternative view.

S. Hahn, J. Glick, L. Kaiser, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison between isotropic and nonisotropic dosimetry systems during intraperitoneal photodynamic therapy

T C Zhu, P Baas, A G Yodh, 2000, Lasers in surgery and medicine.

Photodynamic Therapy: A Light in the Darkness?

S. Hahn, A. Lin, 2009, Clinical Cancer Research.

PhotodynamicTherapy: A Light in the Darkness?

S. Hahn, A. Lin, 2009 .

The emergence of photodynamic therapy as a major modality in cancer treatment

Stephen Hahn, Eli Glatstein, S. Hahn, 1999 .

Detection of hypoxia in human squamous cell carcinoma by EF5 binding.

S M Evans, E M Lord, R. Weber, 2000, Cancer research.

Photodynamic therapy of cancer: An update

Michael R Hamblin, B. Wilson, S. Hahn, 2011, CA: a cancer journal for clinicians.

A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy

James B. Mitchell, S. Hahn, J. Metz, 2004, Clinical Cancer Research.

Neurophysiological consequences of nitroxide antioxidants.

S. Hahn, A. Deluca, J. Mitchell, 1995, Canadian journal of physiology and pharmacology.

Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription.

P. Lambin, S. Hahn, A. Hoffmann, 2016, Journal of the National Cancer Institute.

Ratio of the spherical and flat detectors at tissue surfaces during pleural photodynamic therapy

Timothy C Zhu, Stephen M Hahn, Jeremy Miles, 2002, SPIE BiOS.

Intraperitoneal photodynamic therapy for peritoneal carcinomatosis and sarcomatosis

Timothy C. Zhu, Stephen M. Hahn, Arjun G. Yodh, 2000, BiOS.

Interstitial photodynamic therapy for prostate cancer: a developing modality.

S. Hahn, N. Martin, 2004, Photodiagnosis and photodynamic therapy.

Motexafin Lutetium-Photodynamic Therapy of Prostate Cancer: Short- and Long-Term Effects on Prostate-Specific Antigen

T. Zhu, S. Hahn, K. Cengel, 2008, Clinical Cancer Research.

Preclinical evaluation of motexafin lutetium-mediated intraperitoneal photodynamic therapy in a canine model.

T. Zhu, S. Hahn, D. Fraker, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

A heterogeneous optimization algorithm for reacted singlet oxygen for interstitial PDT

Jarod C Finlay, Timothy C Zhu, Martin D Altschuler, 2010, BiOS.

A heterogeneous algorithm for PDT dose optimization for prostate

Jarod C Finlay, Timothy C Zhu, Jun Li, 2009, BiOS.

In vivo light dosimetry of interstitial PDT of human prostate

Jarod C Finlay, Timothy C Zhu, Jun Li, 2006, SPIE BiOS.

Diffuse optical measurements of tissue blood flow and oxygenation during interstitial prostate PDT

T. Zhu, S. Hahn, A. Yodh, 2006 .

In vivo determination of the absorption and scattering spectra of the human prostate during photodynamic therapy

Jarod C Finlay, Timothy C Zhu, Stephen M Hahn, 2004, SPIE BiOS.